# Clustering Approach 3 : RPPA_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0711884774352618	Range of duration = 2.56 to 357.37, nDeath = 58, nCensor = 50
2	AGE	ANOVA	0.296290575440197	Range of values = 18 to 85, Mean = 56.4037, StdDev = 16.5082
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.0207782966436697	nTypes = 4 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 13/1/15/80
4	GENDER	Fisher's exact test	0.241315103461223	nTypes = 2 (FEMALE/MALE), nPatients = 44/65
5	DISTANT.METASTASIS	Chi-square test	0.461612471255868	nTypes = 4 (M0/M1/M1B/M1C), nPatients = 90/1/2/2, nMissing = 14
6	LYMPH.NODE.METASTASIS	Chi-square test	0.029633020949604	nTypes = 9 (N0/N1/N1A/N1B/N2A/N2B/N2C/N3/NX), nPatients = 56/2/3/13/2/5/4/9/2, nMissing = 13
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 109
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.50573388343272	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 3/11/8/8/10/5/5/3/6/2/11/13/4, nMissing = 20